| STOCKHOLDERS’ DEFICIT Share-Based Compensation Share-based compensation expense for continuing operations, which is included in “Corporate expenses” on the Consolidated Statements of Income (Loss), was $5.8 million and $5.4 million for the three months ended March 31, 2026 and 2025, respectively. Computation of Net Income (Loss) per Share The following table presents the computation of net income (loss) per share for the three months ended March 31, 2026 and 2025: | | | | | | | | | | | | | | | | | (In thousands, except per share data) | | | Three Months Ended March 31, | | | | | | | 2026 | | 2025 | Numerators: | | | | | | | | | Loss from continuing operations | | | | | $ | (49,447) | | | $ | (55,302) | | | Less: Net income from continuing operations attributable to noncontrolling interests | | | | | 600 | | | 670 | | | Net loss from continuing operations attributable to the Company | | | | | (50,047) | | | (55,972) | | | Income from discontinued operations | | | | | 1,453 | | | 118,515 | | | Less: Net income from discontinued operations attributable to noncontrolling interests | | | | | — | | | 34 | | | Net income (loss) from discontinued operations attributable to the Company | | | | | 1,453 | | | 118,481 | | | Net income (loss) attributable to the Company | | | | | $ | (48,594) | | | $ | 62,509 | | | | | | | | | | Denominators: | | | | | | | | | Weighted average common shares outstanding – Basic | | | | | 498,488 | | | 490,332 | | | | | | | | | | Weighted average common shares outstanding – Diluted(1) | | | | | 498,488 | | | 490,332 | | | | | | | | | | Net income (loss) attributable to the Company per share of common stock — Basic and Diluted: | | | | | | | | | Net loss from continuing operations attributable to the Company per share of common stock | | | | | $ | (0.10) | | | $ | (0.11) | | | Net income from discontinued operations attributable to the Company per share of common stock | | | | | — | | | 0.24 | | | Net income (loss) attributable to the Company per share of common stock — Basic and Diluted | | | | | $ | (0.10) | | | $ | 0.13 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(1)Outstanding equity awards equivalent to 45.1 million and 27.4 million shares for the three months ended March 31, 2026 and 2025, respectively, were excluded from the computation of diluted earnings per share as their inclusion would have been anti-dilutive.
|